{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:47:01Z","timestamp":1782478021846,"version":"3.54.5"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000398","name":"Royal College of Radiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJUI Compass"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To use real\u2010world data to determine the clinical risk factors that are predictive of metastatic disease in high\u2010risk prostate cancer (PCa) patients undergoing staging [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010Prostate\u2010Specific Membrane Antigen (PSMA)\u201011 positron emission tomography combined with computed tomography (PET\/CT).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Subjects with newly diagnosed PCa who underwent [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010PSMA\u201011 PET\/CT between 1\/2\/20 and 1\/4\/23, with one or more of three major risk factors (prostate\u2010specific antigen (PSA)\u2009\u2265\u200920, MRI T\u2010stage \u2265 3 or International Society of Urological Pathology (ISUP) grade \u2265 3) were included. Metrics collected included [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010PSMA\u201011 PET\/CT primary index tumour maximum standardized uptake value (SUV\n                      <jats:sub>max<\/jats:sub>\n                      ), TNM stage, tumour histology, patient age, body mass index and treatment type.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 525 subjects were eligible for inclusion. A total of 22.1% had nodal or distant metastases on the baseline [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010PSMA\u201011 PET\/CT (11.8% with one major risk factor, 25.6% with two and 43.5% with three). All three major risk factors (PSA\u2009\u2265\u200920, MRI T\u2010stage \u2265 3, ISUP grade \u2265 3) and the presence of a higher percentage of positive biopsy cores were significant independent risk factors for the presence of metastatic disease on multivariable analysis. Primary index tumour SUV\n                      <jats:sub>max<\/jats:sub>\n                      was associated with clinical risk factors, including ISUP grade in the surgical cohort. A total of 146 (27.8%) subjects underwent a radical prostatectomy, and 379 (72.2%) received non\u2010surgical management (including 242 (46.1%) who received curative intent radiotherapy (RT)).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study provides real\u2010world validation of the clinical risk factors used for the ProPSMA study for [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010PSMA\u201011 PET\/CT scan eligibility, which represent significant independent risk factors for the presence of nodal or distant metastases on baseline [\n                      <jats:sup>68<\/jats:sup>\n                      Ga]Ga\u2010PSMA\u201011 PET\/CT.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bco2.70209","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:44:21Z","timestamp":1782269061000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["[\n                    <sup>68<\/sup>\n                    Ga]Ga\u2010PSMA\u201011 PET\/CT for baseline staging of high\u2010risk prostate cancer: A real\u2010world study"],"prefix":"10.1002","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0916-9123","authenticated-orcid":false,"given":"Amy Rose","family":"Sharkey","sequence":"first","affiliation":[{"name":"School of Biomedical Engineering and Imaging Sciences King's College London, St. Thomas' Hospital  London UK"},{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bassett","sequence":"additional","affiliation":[{"name":"Statsconsultancy Ltd, Longwood Lane  Amersham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manil","family":"Subesinghe","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Medicine King's College London, King's Health Partners, King's College  London UK"},{"name":"London &amp; Guy's and St. Thomas' PET Centre, St. Thomas' Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdip","family":"Azad","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hughes","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"},{"name":"Faculty of Life Sciences and Medicine King's College London, King's Health Partners, King's College  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Popert","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Challacombe","sequence":"additional","affiliation":[{"name":"Guy's and St. Thomas' NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-8134","authenticated-orcid":false,"given":"Gary J. R.","family":"Cook","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering and Imaging Sciences King's College London, St. Thomas' Hospital  London UK"},{"name":"London &amp; Guy's and St. Thomas' PET Centre, St. Thomas' Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00651-2"},{"key":"e_1_2_9_3_1","unstructured":"Prostate cancer: diagnosis and management NICE guideline [NG131].2017; Available from:https:\/\/www.nice.org.uk\/guidance\/ng131"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00670-6"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16608"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268555"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16872"},{"issue":"8","key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2967\/jnumed.122.265205","article-title":"The Diagnostic Value of PSMA PET\/CT in Men with Newly Diagnosed Unfavorable Intermediate\u2010Risk Prostate Cancer","volume":"64","author":"Hagens MJ","year":"2022","journal-title":"J Nucl Med: Off Publ, Soc Nucl Med"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00326-7"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.38550"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06278-1"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.05.006"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001698"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04782-2"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3771"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071508"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190314"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222010"}],"container-title":["BJUI Compass"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bco2.70209","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bco2.70209","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bco2.70209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:55:57Z","timestamp":1782474957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1002\/bco2.70209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/bco2.70209"],"URL":"https:\/\/doi.org\/10.1002\/bco2.70209","archive":["Portico"],"relation":{},"ISSN":["2688-4526","2688-4526"],"issn-type":[{"value":"2688-4526","type":"print"},{"value":"2688-4526","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2025-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70209"}}